San Francisco Sentry Investment Group’s Ionis Pharmaceuticals IONS Stock Holding History

San Francisco Sentry Investment Group’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-17	Closed	-$1K	–	765
2020 Q1	$1K	Hold	17	–	–	﹤0.01%	768
2019 Q4	$1K	Hold	17	–	–	﹤0.01%	836
2019 Q3	$1K	Hold	17	–	–	﹤0.01%	836
2019 Q2	$1K	Hold	17	–	–	﹤0.01%	837
2019 Q1	$1K	Hold	17	–	–	﹤0.01%	873
2018 Q4	$1K	Buy	+17	New	+$867	﹤0.01%	869
2014 Q2	–	Sell	-16,650	Closed	-$719K	–	643
2014 Q1	$719K	Hold	16,650	–	–	0.23%	98
2013 Q4	$663K	Hold	16,650	–	–	0.23%	104
2013 Q3	$625K	Sell	16,650 -3,350	-17%	-$100K	0.24%	100
2013 Q2	$537K	Buy	+20,000	New	+$425K	0.19%	111

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

San Francisco Sentry Investment Group's IONS Position: Q2 2020 in Review

San Francisco Sentry Investment Group sold out of Ionis Pharmaceuticals (IONS) in Q2 2020, closing a stake of 17 shares — an estimated $1K sold.

San Francisco Sentry Investment Group first reported a position in IONS in Q2 2013 and held it in 10 quarters. The position peaked at $719K in Q1 2014. 376 funds tracked by Wall St. Rank hold IONS as of Q2 2020.

San Francisco Sentry Investment Group reported no remaining Ionis Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
San Francisco Sentry Investment Group sold 17 Ionis Pharmaceuticals shares in Q2 2020, an estimated $1K.
San Francisco Sentry Investment Group first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 10 quarters.
San Francisco Sentry Investment Group's Ionis Pharmaceuticals position peaked at $719K in Q1 2014.
376 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2020.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2020, filed 17 Jul 2020.